NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

At this stage, it’s moot and regardless of bulletin board chatter about old ideas, all the facts literally are out and it’s quite obvious in my view. There would be no point in putting out such a PR or further details about that. It is not currently material nor has it really ever been likely to be material for approval beyond the details we already know and those are: 1) the placebo arm was not fit for purpose; 2) but they did ultimately repurpose those patients for recurrent GBM; 3) they extended the length of the trial to get OS data because PFS data was also not fit for purpose in that it was not correlating, clearly, with survival data, and that is the entire purpose of PFS data; 4) they were given permission to and hired an outside firm to create a blindly created, external placebo arm, for comparison of OS date; 5) all kinds of additional statistical work was done to ensure that that arm was very accurate and likely to be true and fit for purpose; and 5) end results were published and validated DCVax-L as statistically efficacious and valuable as a new potential treatment for GBM and possibly other cancers given it’s mode of action.

I do not think there is any other reason to say more except to feed trolls and people affected by trolls. It definitely would not help either the regulatory processes of approvals, nor likely really lead to investors being “more informed”, given what we know shorts do with such information and even undeniably positive information.

It would serve no one’s interest but the shorts.

We will likely hear the full story once this is fully approved and in hospitals giving encouraging or even miraculous results. Then it won’t matter what shorts say. And they will likely be on to new companies and new skulduggery.